May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Aqueous Humor Dynamics in Monkeys After Topical R(+)–DOI
Author Affiliations & Notes
  • M. Okka
    Ophthalmology & Visual Science, University Wisconsin Med Sch, Madison, WI
  • B.T. Gabelt
    Ophthalmology & Visual Science, University Wisconsin Med Sch, Madison, WI
  • T.R. Dean
    Alcon Research, Ltd, Fort Worth, TX
  • P.L. Kaufman
    Ophthalmology & Visual Science, University Wisconsin Med Sch, Madison, WI
  • Footnotes
    Commercial Relationships  M. Okka, None; B.T. Gabelt, None; T.R. Dean, Alcon Laboratories E; P.L. Kaufman, Alcon Laboratories F.
  • Footnotes
    Support  Alcon Laboratories, NIH EY02698, RPB, OPREF
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5034. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Okka, B.T. Gabelt, T.R. Dean, P.L. Kaufman; Aqueous Humor Dynamics in Monkeys After Topical R(+)–DOI . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5034.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the effects of R(+)–DOI, a selective 5–HT2 agonist, on intraocular pressure (IOP) and aqueous humor dynamics in monkeys. Methods: Normotensive cynomolgus monkeys were treated topically once daily with 4x5µl 0.5% R(+)–DOI (n=8) to one eye, vehicle to the opposite eye. 6 hour IOP response (Goldmann) and slit lamp examination (SLE) were determined prior to dosing and on the 3rd day of treatment. Aqueous humor formation (AHF) was determined by fluorophotometry encompassing hours 3–8 after the 3rd dose (n=8). In another group of monkeys (n=8), beginning 3.5 hr after the 4th or 5th dose, AHF was measured by dilution of radio–iodinated monkey albumin (I–MSA) perfused through the anterior chamber, and flow to blood (FTB) by accumulation of I–MSA in the general circulation. Uveoscleral outflow (Fu) = AHF – FTB. FTB was determined at both spontaneous and elevated pressures allowing calculation of trabecular outflow facility (Ctrab). Total outflow facility (Ctot) was determined at the conclusion of the isotope measurements by two–level constant pressure perfusion. Results:IOP lowering in treated (T) eyes was compared to the opposite control (C) eyes corrected for the 6 hour IOP baseline prior to the first dose. Following the 3rd dose of 0.5% R(+)–DOI (4x5µl) IOP was significantly (p<0.01, n=7) decreased by 1.4–4.7 mmHg over the 6 hrs (pretreatment IOP = 15.0±0.4mmHg). AHF (fluoro) was increased by 16±6% (p<0.025) in T compared to C eyes post–treatment corrected for baseline. Isotope dilution showed that AHF increased by 30% (p<0.01), FTB decreased by 28% and Fu increased by 241% (p<0.05). Ctot and Ctrab were unchanged. Conclusions:R(+)–DOI, a selective 5–HT2 agonist, causes a small but significant increase in AHF, and lowers IOP in normotensive monkeys primarily by increasing Fu.

Keywords: intraocular pressure • outflow: ciliary muscle • outflow: trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×